Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial

Phase 3

Completed

• Conditions: ُSurgical site infection was assessed; Superficial, Pelvic, infection, Cesarean

• Registration Number: TCTR20201204002
• Lead Sponsor: rmia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-04-02
• Study Start: 2020-12-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 462

Inclusion Criteria

All participants with emergency cesarean section, satisfied to participate without any sensitivity to antibiotics.

Exclusion Criteria

Exclusion criteria were receiving antibiotics in addition to routine cefazolin, intraoperative atony event, placenta previa, decolonization, massive bleeding leading to blood transfusion, BMI> 35 kg/m2, taking immunosuppressive drugs and corticosteroids, known underlying diseases including autoimmune, lymphoblastic, rheumatological and cardiac diseases, elective cesarean section, febrile patients at the time of hospitalization

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of surgical site infection start of the project, visit on day 7-10 and follow-up on day 30. Observation

Secondary Outcome Measures

Name	Time	Method
HbA1C start of the project, visit on day 7-10 and follow-up on day 30. Blood sample